NCT05327868

Brief Summary

In the Lean and Obese Dietary Inflammation (LODI) study, the primary goal is to determine the effect of short-term intake of high dietary fat (5 days) compared to low fat intake (5 days) in a cross-over design in older adults (men and women) with normal body weight or obesity. Inflammation will be examined by measuring serum endotoxin and other markers, as well as the fecal microbiota.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 14, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2023

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2024

Enrollment Period

10 months

First QC Date

February 28, 2022

Last Update Submit

March 21, 2024

Conditions

Keywords

obesitylean individualsolder adultsmicrobiomedietary fat

Outcome Measures

Primary Outcomes (2)

  • Change in Endotoxin from Low to High fat diet

    serum and stool

    Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks

  • Change in Microbiome composition

    stool

    Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks

Secondary Outcomes (5)

  • Inflammatory markers

    Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks

  • Zonulin

    Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks

  • Lipopolysaccharide binding protein (LBP)

    Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks

  • Toll like receptor-4 and Null 2 stimulation

    Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks

  • Endotoxin in response to a meal

    Change over 5 hour MMT

Other Outcomes (10)

  • Change in Glucose in response to a meal

    Change over 5 hour MMT

  • Change in insulin in response to a meal

    Change over 5 hour MMT

  • Inflammatory markers in response to a meal

    Change over 5 hour MMT

  • +7 more other outcomes

Study Arms (2)

Obese

EXPERIMENTAL

BMI in Obesity range

Other: Low Fat Diet (LFD)Other: High Fat Diet (HFD)

Normal weight (lean)

EXPERIMENTAL

Normal body weight

Other: Low Fat Diet (LFD)Other: High Fat Diet (HFD)

Interventions

Subjects will be asked to adhere to a low fat diet (assigned in random order) and be counseled by a dietitian using 5 days of sample menus, monitored online using a shared nutrient analysis program, and supplied with low fat foods to increase compliance

Also known as: low fat diet
Normal weight (lean)Obese

Subjects will be asked to adhere to a high fat diet that is rich in SFAs (assigned in random order) and be counseled by a dietitian using sample 5 days of menus, monitored online using a shared nutrient analysis program, and supplied with high fat foods to increase compliance

Also known as: high fat (high SFA) diet
Normal weight (lean)Obese

Eligibility Criteria

Age50 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or Women
  • Age 50-79 years (only postmenopausal women \> 2 years)
  • Body mass index (20-25 kg/m2; and 30-40 kg/m2)\*

You may not qualify if:

  • Diagnosed with, active, or history of liver cirrhosis, chronic or persisting hepatitis
  • Diagnosed with, active, or history of cancer
  • History of gastrointestinal disease or surgical procedure for weight loss.
  • Diagnosed with immune diseases, type 2 diabetes, pancreatitis, or infectious diseases
  • Any surgery in the past 6 months
  • Currently using or have used antibiotics continuously \> 3 days in the past 3 months
  • Regular use of medications for that affect the gastrointestinal tract, cholecystitis, urinary tract infection, severe organic diseases including coronary heart disease, myocardial infarction, infectious diseases including pulmonary tuberculosis and AIDS
  • Known allergy or intolerance to any ingredients in the dietary intervention program
  • Alcohol or illicit drug abuse
  • Current Smoker or have quit smoking in the past 3 months
  • Recent colonoscopy (within the previous two months)
  • Inability to follow any of the experimental diets (including low or high fat diet) or to perform the collections required for this study
  • Participants will also be excluded if they have extreme dietary habits, extreme levels of physical or athletic activity, or by changes in body weight \>5 lbs. during the last 6 months
  • Uncontrolled hypertension or uncontrolled hyperlipidemia in abnormal ranges.
  • Participation in another clinical research trial that may interfere with the results of this study.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers University

New Brunswick, New Jersey, 08901, United States

Location

Related Publications (1)

  • Ogilvie AR, Onishi JC, Schlussel Y, Kumar A, Haggblom MM, Kerkhof LJ, Shapses SA. Short-term high fat diet-induced metabolic endotoxemia in older individuals with obesity: a randomized crossover study. Am J Clin Nutr. 2025 Aug;122(2):601-611. doi: 10.1016/j.ajcnut.2025.06.001. Epub 2025 Jun 4.

MeSH Terms

Conditions

ObesityInflammation

Interventions

Diet, Fat-RestrictedDiet, High-FatDiet

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Sue Shapses, PhD

    Rutgers, the State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 28, 2022

First Posted

April 14, 2022

Study Start

March 1, 2022

Primary Completion

January 1, 2023

Study Completion

February 11, 2023

Last Updated

March 25, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Individual participant data that underlie the results and after deidentification will be shared upon request for researchers who provide a methodologically sound proposal (and IRB approved).

Locations